TG Therapeutics Climbs By 14% After Presenting at J.P Morgan Healthcare Conference
TG Therapeutics, Inc. (NASDAQ:TGTX) today participated in the 36th Annual J.P Morgan Healthcare Conference in San Francisco and as a result, the stock has increased by almost 15%. TG Therapeutics is a biopharmaceutical company engaged ... [Read]
Novavax Shares Shoot Up Over 50% Amid Promising Trial Developments
Biotech company Novavax (NASDAQ:NVAX) is enjoying a share rise of 59.40% as of 4:00 PM EST today on the heels of announcing encouraging results in an immunization study. This brings their share value up from ... [Read]
Akers Biosciences stock soaring – but why?
It’s pharma fever on the stock market today as the likes of Diffusion Pharmaceuticals (NASDAQ:DFFN) and most notably Pain Therapeutics (NASDAQ:PTIE) have seen stock climb by 42.98% and 114.22% respectively. These heady rises come amid ... [Read]
More Upside is Ahead for Spectrum Pharmaceutical Stock
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI) has generated substantial share price appreciation in the last twelve months, due to its strategy of developing drugs in Hematology and Oncology. It currently offers six oncology and hematology drugs, and ... [Read]
Axsome Therapeutics Shares Drop Following ‘Disappointing’ Drug Trial Outcome
It’s a gray morning for Axsome Therapeutics. Shares in the biopharmaceutical company have fallen by -36.94%, bringing the last price to 3.50 as of 2:38 PM EST. The sink comes amid reports that their trial ... [Read]
Diffusion Pharmaceuticals Presents TSC Candidate at Biotech Conference, Stock Climbs 35%
Diffusion Pharmaceuticals Inc. (NASDAQCM:DFFN) has experienced a stock increase of 35% today on the Nasdaq Capital Market. At the time of writing, the stock has moved $0.43, from the previous closing price of $1.21 to ... [Read]
Should You Be Investing in Biotech Stocks? Pain Therapeutics Up 150% and GT Biopharma Up Nearly 15%
What a way to start off the week! If you’re an investor, and you’re looking to spice up your investment portfolio, why not invest in some biotech stocks? Considering the industry has been doing quite ... [Read]
Should you Buy Codexis Despite Lofty Valuations?
Codexis Inc. (NASDAQ:CDXS) has stunned investors with the massive growth of 68% in the last twelve months, soaring significantly by 213% in the last five years. CDXS stock is currently trading around $8.5 a share, ... [Read]
Axovant Sciences Ltd. Shares Have Dropped Over 50% Today, Here’s Why.
Switzerland-based Axovant Sciences Ltd (NASDAQ:AXON) shares have plummeted over 50% today as it announces it has scrapped its program and experiments for curing a type of dementia. The drug was called intrepirdine and it has ... [Read]
Ohr Pharmaceutical Experiences Disappointing 80% Drop in Stock After Reporting Even More Disappointing Test Results
Ohr Pharmaceutical, Inc. (NASDAQ:OHRP) disappoints this week, the stock dropping over 80% – a complete one-eighty from many other biotech companies that have been soaring this week. Ohr Pharmaceutical stock experienced a drop of $1.6462, ... [Read]